# PF-06664178

Source: https://onco.cc/drugs/pf-06664178/  
OnCo record `pf-06664178` (Treatment). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

This early TROP-2 antibody-drug conjugate was tested in a study that stopped before completing development.

## Summary

NCT02122146 is terminated with 31 actual participants. The registry reports a business-related decision based on the overall results; this is a historical program, not a recruiting treatment opportunity.

## Fields

- Kind: Treatment
- Status: historic
- Last checked: 2026-10-06
- Modality: Antibody-drug conjugate
- Mechanism: Anti-TROP2 antibody-drug conjugate.

## Sources

- ClinicalTrials.gov NCT02122146: https://clinicaltrials.gov/study/NCT02122146

## Connected records

- targets: [TROP2](https://onco.cc/targets/trop2/)
- trials: [A Study Of PF-06664178 In Patients With Advanced Solid Tumors](https://onco.cc/trials/nct02122146/)

---
JSON: https://onco.cc/api/v1/entities/pf-06664178.json